Applicability of glucocorticoid toxicity index in pemphigus: Comparison between two groups of rituximab-treated and rituximab-naïve patients.

Autor: Mazaherpour E; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran., Kianfar N; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran., Dasdar S; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran., Sedaghat M; Department of Community Medicine, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran., Seyrafi H; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran., Balighi K; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran., Saberi F; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran., Nili A; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran., Farimani Z; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran., Azar PM; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran., Mahmoodi H; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran., Murrell DF; Department of Dermatology, St George Hospital, Sydney, New South Wales, Australia.; Faculty of Medicine, University of New South Whales, Sydney, New South Wales, Australia., Daneshpazhooh M; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.

Publikováno v: Dermatologic therapy [Dermatol Ther] 2022 Dec; Vol. 35 (12), pp. e15902. Date of Electronic Publication: 2022 Oct 17.

Botulinum toxin injection as a single or combined treatment with non-cross-linked high molecular weight and low molecular weight hyaluronic acid gel for neck rejuvenation: A randomized clinical trial.

Autor: Noormohammadpour P; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Science, Tehran, Iran., Ehsani A; Department of Dermatology, Tehran University of Medical Science, Tehran, Iran., Mahmoudi H; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Science, Tehran, Iran., Razavi Z; Department of Dermatology, Razi Hospital, Tehran University of Medical Science, Tehran, Iran., Balighi K; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Science, Tehran, Iran., Azar PM; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Science, Tehran, Iran., Firooz A; Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran., Jabbari A; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Science, Tehran, Iran.

Publikováno v: Dermatologic therapy [Dermatol Ther] 2022 Oct; Vol. 35 (10), pp. e15673. Date of Electronic Publication: 2022 Aug 08.

Anti-Xga suspected of causing a transfusion reaction.

Autor: Azar PM, Saji H, Yamanaka R, Hosoi T

Publikováno v: Transfusion [Transfusion] 1982 Jul-Aug; Vol. 22 (4), pp. 340-1.